2B70:XETRA:XETRA-iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (EUR)

ETF | Others |

Last Closing

USD 5.489

Change

-0.13 (-2.33)%

Market Cap

USD 0.52B

Volume

0.14M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-25 )

ETFs Containing 2B70:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.74% 12% F 18% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.74% 12% F 18% F
Trailing 12 Months  
Capital Gain 1.72% 26% F 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.72% 25% F 32% F
Trailing 5 Years  
Capital Gain 28.26% 53% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 28.26% 52% F 54% F
Average Annual (5 Year Horizon)  
Capital Gain 6.75% 64% D 62% D
Dividend Return 6.75% 63% D 60% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.67% 41% F 52% F
Risk Adjusted Return 45.98% 59% D- 62% D
Market Capitalization 0.52B 69% C- 61% D-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.